关于用中国专利药物治疗社区性肺炎的指导方针
Minghang Wang1, Huiguo Liu2, Yaolong Chen3
1The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450046, China; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases co-constructed by Henan province & Education Ministry of P.R. China, Zhengzhou 450000, China.
这项研究提供了基于证据的指导方针,用于使用中国专利药物 (CPM) 治疗社区获得性肺炎 (CAP). 针对严重和不严重的CAP提出了十项建议,其中突出的是Tanreqing和Reduning注射.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 基于证据的医学 基于证据的医学
背景情况:
- 社区获得性肺炎 (CAP) 是一种常见的传染病,在老年人中越来越严重.
- 抗菌素耐药性对传统的CAP治疗提出了挑战.
- 由于耐受性,中国专利药 (CPM) 在中国广泛用于CAP,但缺乏基于证据的指导方针,导致滥用.
研究的目的:
- 为中国专利药物 (CPM) 在治疗社区获得性肺炎 (CAP) 中的临床应用制定基于证据的指导方针.
- 通过提供明确的,基于共识的建议来解决CPM的滥用问题.
主要方法:
- 一个指导方针小组通过调查确定了六个临床问题.
- 进行了系统的文献搜索,元分析和GRADE评估.
- 使用德尔菲方法和专家共识,最终确定了10项建议.
主要成果:
- 针对成年人严重和不严重的CAP,制定了建议.
- 对于严重的CAP,建议使用Tanreqing,Reduning,Xuebijing,Shenfu和Shenmai注射.
- 对于不严重的CAP,建议使用坦雷青,红,连华青文,青飞小洋和舒峰建德.
结论:
- 在全球范围内,CPM在管理农业政策方面显示出巨大的潜力.
- 需要进一步进行高质量的研究,以加强CMP在CAP治疗中的证据基础.
更多相关视频
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
相关概念视频
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
